balicatib,
N-(1-((cyanomethyl)carbamoyl)cyclohexyl)-4-(4-propylpiperazin-1-yl)benzamide,
Balicatib,
354813-19-7,
AAE-581,
AAE 581,
UNII-E00MVC7O57,
AAE581,
CHEMBL371064,
E00MVC7O57,
N-[1-(cyanomethylcarbamoyl)cyclohexyl]-4-(4-propylpiperazin-1-yl)benzamide,
AK340949,
N-(1-((cyanomethyl)carbamoyl)cyclohexyl)-4-(4-propylpiperazin-1-yl)benzamide,
N-(1-(cyanomethylcarbamoyl)cyclohexyl)-4-(4-propylpiperazin-1-yl)benzamide,
Benzamide, N-[1-[[(cyanomethyl)amino]carbonyl]cyclohexyl]-4-(4-propyl-1-piperazinyl)-,
Balicatib [INN],
N-{1-[(cyanomethyl)carbamoyl]cyclohexyl}-4-(4-propylpiperazin-1-yl)benzamide,
Balicatib, AAE-581,
GTPL7861,
SCHEMBL1587772,
BDBM19855,
AOB5424,
DTXSID10188989,
EX-A362,
LLCRBOWRJOUJAE-UHFFFAOYSA-N,
BCP09098,
ZINC3954923,
MFCD19443790,
AKOS025149083,
CS-2623,
DB12239,
basic piperazine-containing compound, 10,
NCGC00371151-06,
4CA-0249,
BC600452,
HY-15100,
QC-11395,
AB0098420,
B3265,
FT-0700298,
J-690287,
N-[1-(cyanomethylcarbamoyl)cyclohexyl]-4-(4-propylpiperazin-1-yl),
AAE-581|||N-[1-(Cyanomethylcarbamoyl)cyclohexyl]-4-(4-propylpiperazin-1-yl)benzamide,
N-[1-(Cyanomethyl-carbamoyl)-cyclohexyl]-4-[4-(1-propyl)-piperazin-1-yl]-benzamide,
D01LNG,
ACN-039844,
CID10201696,
A12020,
N-Methyl-2-(2-pyridinyl)-N-[2-(2-pyridinyl)ethyl]ethanamine,